We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Mylan Could Launch Generic Norvasc During Pediatric Extension
Mylan Could Launch Generic Norvasc During Pediatric Extension
May 2, 2006
Mylan Laboratories could try to capitalize on its first-to-file status for Pfizer’s blood-pressure drug Norvasc by launching during the pediatric exclusivity period, according to one analyst.